VSIR and cholangiocarcinoma: In cholangiocarcinoma, inhibition of mIDH1 correlates with induction of interferon responsive molecules, such as PD-L1, PD1, and VISTA/BY-H5, on tumor infiltrating immune cells and lower lymphocytes counts within mIDH1 versus wildtype tumors.26